ArticleTurk gogus kalp damar cerrahisi dergisi2026
Endovascular treatment of thoracoabdominal aortic pathologies using 3D printer-assisted physician-modified stent-grafts.
Article in Turk gogus kalp damar cerrahisi dergisi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term outcomes and prognostic factors of hybrid aortic arch repair: a 15-year cohort study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thoracoabdominal aortic aneurysms (TAAAs) and dissections are among the most challenging vascular diseases. Endovascular interventions have gained prominence in the treatment of these diseases in recent years. However, the frequent involvement of the visceral or supra-aortic artery ostia in the proximal or distal landing zone increases the complexity of the procedure. Therefore, several techniques have been developed to address this challenge. In this study, we present our experience with thoracic endovascular aortic repair using three-dimensional (3D) printer-assisted physician-modified stent-grafts (PMSGs) for thoracoabdominal aortic pathologies involving the left subclavian artery, celiac trunk, superior mesenteric artery, or renal arteries. Methods: Between January 2020 and January 2023, a total of 18 patients presenting with complex aortic pathologies were screened for eligibility. Four patients were excluded because of active systemic infection/mycotic etiology (n=2) or unsuitable iliofemoral access (n=2). Consequently, 14 patients (12 with TAAAs and 2 with aortic arch dissections) were treated using 3D printer-assisted PMSGs. All aortic arch dissections extended to the left subclavian artery. Results: Fourteen patients underwent surgery with 3D printing guidance. The technical success rate was 92.8%. There were no perioperative deaths. The mean age was 68.07±10.6 years. The mean procedure time was 4.27±1.23 hours, including a mean custom graft preparation time of 1.3±0.6 hours. The mean intensive care unit stay was 5.64±11.54 days, and the mean hospital stay was 13.07±10.6 days. All 14 patients were followed for 2-12 months, with a mean follow-up of 6 months. Mortality occurred in 1 patient (7.1%). Conclusion: The 3D printer-assisted PMSG technique offers significant technical advantages by improving procedural precision and simplifying the creation of fenestrations for complex aortic pathologies. Our findings suggest that this technique provides a high technical success rate and represents a safe and feasible alternative for preserving vital side branches, particularly in settings where patient-specific custom-made grafts are not readily available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.